The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024)

The Guidelines for Clinical Practice for carriers of pathogenic variants in clinically relevant cancer predisposition genes define the steps of primary and secondary prevention that should be provided to these individuals at high risk of developing hereditary cancer in the Czech Republic. The drafting of the guidelines was organized by the Oncogenetics Working Group of the Society for Medical Genetics and Genomics of J. E. Purkyně Czech Medical Society (SLG ČLS JEP) in cooperation with the representatives of oncology and oncogynecology. The guidelines are based on the current recommendations of the National Comprehensive Cancer Network (NCCN), European Society of Medical Oncology (ESMO) and take into account the capacity of the Czech healthcare system.

Authors

Publication Details

Journal
Klinicka onkologie
Published
2024-08-15
DOI
https://doi.org/10.48095/ccko2024292
Citations
4
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
2.20
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024)

Zdeňka Vlčková, Václava Curtisová, Markéta Palácová, Zdeněk Kleibl et al.
4 citations
Klinicka onkologie
BRCA gene mutations in cancer
2.20
article

The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024)

Zdeňka Vlčková, Václava Curtisová, Markéta Palácová, Zdeněk Kleibl, Alena Puchmajerová, Kamila Veselá, Jana Soukupová, Markéta Janatová, H. Štěpánková, Monika Koudová, Šárka Vilímová, Petra Kleiblová, Ilja Tachecí, Ondřej Urban, Lenka Foretová, Vít Weinberger, Mária Šenkeříková, Martina Zimovjanová, Ondřej Havránek, Ivan Šubrt, Oľga Dubová, Pavel Tesner, Michal Zikán, David Cibula, Katarína Petráková, Jiří Presl, Michal Vočka, Sviatlana Paulich, Věra Krutílková, Jan Novotný, Markéta Hojsáková, Anna Germanová, Miroslava Hudcova, Zuzana Šimková
article en
4 citations

Abstract

The Guidelines for Clinical Practice for carriers of pathogenic variants in clinically relevant cancer predisposition genes define the steps of primary and secondary prevention that should be provided to these individuals at high risk of developing hereditary cancer in the Czech Republic. The drafting of the guidelines was organized by the Oncogenetics Working Group of the Society for Medical Genetics and Genomics of J. E. Purkyně Czech Medical Society (SLG ČLS JEP) in cooperation with the representatives of oncology and oncogynecology. The guidelines are based on the current recommendations of the National Comprehensive Cancer Network (NCCN), European Society of Medical Oncology (ESMO) and take into account the capacity of the Czech healthcare system.

Klinicka onkologieVol. 37(4)
Partnerships for the goals
Openalex Percentile: Top 12%
BRCA gene mutations in cancer
2.20
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.